CYP2C19 and coronary artery disorder: Through the research of 654 patients with coronary heart disease, Mao Chen et al. [16] found that the homozygous CYP2C19*2/*2 genotype was an independent determinant of adverse vascular events in Chinese patients with coronary artery disease (CAD).